Our top pick for
Silk Road Medical, Inc is a medical devices business based in the US. Silk Road Medical shares (SILK) are listed on the NASDAQ and all prices are listed in US Dollars.
|52-week range||USD$20.84 - USD$75.8|
|50-day moving average||USD$57.6118|
|200-day moving average||USD$60.8221|
|Wall St. target price||USD$67.83|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-6.304|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|Revenue TTM||USD$75.2 million|
|Gross profit TTM||USD$53.9 million|
|Return on assets TTM||-16.92%|
|Return on equity TTM||-52.81%|
|Market capitalisation||USD$1.9 billion|
TTM: trailing 12 months
There are currently 2.8 million Silk Road Medical shares held short by investors – that's known as Silk Road Medical's "short interest". This figure is 12.8% up from 2.5 million last month.
There are a few different ways that this level of interest in shorting Silk Road Medical shares can be evaluated.
Silk Road Medical's "short interest ratio" (SIR) is the quantity of Silk Road Medical shares currently shorted divided by the average quantity of Silk Road Medical shares traded daily (recently around 418647.49262537). Silk Road Medical's SIR currently stands at 6.78. In other words for every 100,000 Silk Road Medical shares traded daily on the market, roughly 6780 shares are currently held short.
However Silk Road Medical's short interest can also be evaluated against the total number of Silk Road Medical shares, or, against the total number of tradable Silk Road Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Silk Road Medical's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Silk Road Medical shares in existence, roughly 80 shares are currently held short) or 0.1037% of the tradable shares (for every 100,000 tradable Silk Road Medical shares, roughly 104 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Silk Road Medical.
Find out more about how you can short Silk Road Medical stock.
We're not expecting Silk Road Medical to pay a dividend over the next 12 months.
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products includes ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was founded in 2007 and is headquartered in Sunnyvale, California.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.